Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Long-term stability of acquired drug resistance and resistance associated mutations in the fungal pathogen Nakaseomyces glabratus (Candida glabrata).

Frontiers in cellular and infection microbiology - 1 Jan 2024

Ksiezopolska Ewa, Schikora-Tamarit Miquel Àngel, Carlos Nunez-Rodriguez Juan, Gabaldón Toni

Abstract excerpt

The limited number of available antifungal drugs and the increasing number of fungal isolates that show drug or multidrug resistance pose a serious medical threat. Several yeast pathogens, such as Nakaseomyces glabratus (Candida glabrata), show a remarkable ability to develop drug resistance during treatment through the acquisition of genetic mutations. However, how stable this resistance and the underlying...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antifungal Agents
Share to Candida glabrata

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Fungal

Share to Drug Resistance, Multiple, Fungal

Share to Fluconazole

Share to Microbial Sensitivity Tests

Share to Mutation

Share to Phenotype

Source

Open in PubMed Open full text

Identifiers

PMID: 39077431
DOI: 10.3389/fcimb.2024.1416509
PMCID: PMC11284152

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Long-term stability of acquired drug resistance and resistance associated mutations in the fungal pathogen Nakaseomyces glabratus (Candida glabrata).PMID 39077431Read ↗

Narrow mutational signatures drive acquisition of multidrug resistance in the fungal pathogen Candida glabrata.Semantic proximity Read ↗

Genomic diversity across <i>Candida auris</i> clinical isolates shapes rapid development of antifungal resistance <i>in vitro</i> and <i>in vivo</i>Semantic proximity Read ↗

Genomic Diversity across Candida auris Clinical Isolates Shapes Rapid Development of Antifungal Resistance In Vitro and In VivoSemantic proximity Read ↗

Combined genetic and environmental factors shape the landscape of anti-fungal tolerance in Nakaseomyces glabratusSemantic proximity Read ↗

Genomic description of the first multidrug-resistant Nakaseomyces glabratus (Candida glabrata) strain detected in Costa Rica.Semantic proximity Read ↗

The evolution of drug resistance in clinical isolates of Candida albicans.Semantic proximity Read ↗

Population dynamics and the evolution of antifungal drug resistance in Candida albicans.Semantic proximity Read ↗

Candida albicans Genetic Background Influences Mean and Heterogeneity of Drug Responses and Genome Stability during Evolution in Fluconazole.Semantic proximity Read ↗

The Microevolution of Antifungal Drug Resistance in Pathogenic FungiSemantic proximity Read ↗

Antifungal tolerance and resistance emerge at distinct drug concentrations and rely upon different aneuploid chromosomesSemantic proximity Read ↗

In-host microevolution of Aspergillus fumigatus: A phenotypic and genotypic analysis.Semantic proximity Read ↗

Micafungin microevolution in Candida auris reveals resistance development without in vivo fitness compromise.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.